Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer

被引：0
|
作者：
Maria Di Bartolomeo
Filippo Pietrantonio
Antonia Martinetti
Roberto Buzzoni
Arpine Gevorgyan
Emilio Bajetta
机构：
[1] Fondazione IRCCS Istituto Nazionale dei Tumori,Medical Oncology Unit 2
来源：
Drugs & Aging | 2011年 / 28卷
关键词：
Vascular Endothelial Growth Factor; Bevacizumab; Capecitabine; Metastatic Colorectal Cancer; mCRC Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Although major progress has been achieved in the treatment of metastatic colorectal cancer with the employment of biological antiangiogenic agents, several questions remain open for discussion regarding the use of this therapy in elderly patients with metastatic colorectal cancer.
引用
收藏
页码：83 / 91
页数：8
相关论文
共 50 条
  • [1] Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
    Di Bartolomeo, Maria
    Pietrantonio, Filippo
    Martinetti, Antonia
    Buzzoni, Roberto
    Gevorgyan, Arpine
    Bajetta, Emilio
    [J]. DRUGS & AGING, 2011, 28 (02) : 83 - 91
  • [2] Bevacizumab in elderly patients with metastatic colorectal cancer
    Sclafani, Francesco
    Cunningham, David
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (01) : 78 - 88
  • [3] Bevacizumab treatment in the elderly patient with metastatic colorectal cancer
    Di Bartolomeo, Maria
    Maggi, Claudia
    Ricchini, Francesca
    Pietrantonio, Filippo
    Iacovelli, Roberto
    de Braud, Filippo
    Inno, Alessandro
    [J]. CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 127 - 133
  • [4] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Cherciu, Nelly
    Petria, Cristina
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
  • [5] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Benedik, Jernej
    Volk, Neva
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [6] Use of bevacizumab in elderly patients with metastatic colorectal cancer: Review
    Francois, E.
    Guerin, O.
    Follana, P.
    Evesque, L.
    Mari, V.
    Aparicio, T.
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2011, 2 (01) : 64 - 71
  • [7] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    [J]. British Journal of Cancer, 2010, 102 : 1468 - 1473
  • [8] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
  • [9] Treatment with bevacizumab in patients with metastatic colorectal cancer (mCRC)
    Ocvirk, Janja
    Rebersek, Martina
    Boc, Marko
    Motara, Maja Ebert
    Mesti, Tanja
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Role of circulating tumour marker CA 19.9 and antiangiogenic therapy with bevacizumab in patients with metastatic colorectal cancer on first line systemic treatment
    Formica, V
    Portarena, I
    Fiaschetti, V
    Del Vecchio, G.
    Massara, M.
    Sica, G.
    Sileri, P.
    Grenga, I
    Pallone, F.
    Roselli, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 96 - 97
12345